|
|
|||||||||||
Clare Mental Health Services, Ennis, County Clare
James Connolly Memorial Hospital, Blanchardstown, Dublin
Department of Biostatistics, University of Limerick
Department of Adult Psychiatry, Midwestern Regional Hospital, Limerick, Ireland, e-mail: meaghermob{at}eircom.net
AIMS AND METHOD
Prescribing in everyday practice frequently deviates from evidence-based guidelines. Previous work compared practice in a community mental health service with evidence-based guidelines and identified factors related to suboptimal prescribing. This study reports the impact of a multifaceted intervention on prescribing practice. A Prescribing Practice Quality (PPQ) score was generated from six key aspects of prescribing at initial assessment and again 1 year later after an intervention to reduce suboptimal prescribing practices.
RESULTS
A total of 264 patients were attending the service at both the initial and follow-up phase and were thus exposed to the prescribing intervention. In this population, PPQ scores were significantly lower at follow-up (0.96 v. 0.67, P<0.001). Improved prescribing practice was predicted by receipt of adjunctive supportive inputs, such as anxiety management (P=0.003).
Similarly, mean PPQ scores substantially decreased when the total patient population was considered at each time point (0.75 in 2001 and 0.52 in 2002). These results suggest a reduction in both the initiation and continuation of suboptimal practices.
CLINICAL IMPLICATIONS
Prescribing in real-world settings can be improved by interventions that target multiple aspects of service activity. The provision of supportive inputs is a key factor in improving practice.
This article has been cited by other articles:
![]() |
D. Meagher, A. Pullela, M. Meisinger, N. Geaney, and S. O'Brien Five-year follow-up of an evidence-based prescribing intervention Psychiatr. Bull., May 1, 2008; 32(5): 183 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hannan, Z. Hamzah, H. O. Akinpeloye, and D. Meagher Venlafaxine--mirtazapine combination in the treatment of persistent depressive illness J Psychopharmacol, March 1, 2007; 21(2): 161 - 164. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| British Journal of Psychiatry | Advances in Psychiatric Treatment | All RCPsych Journals |